An RCT of a Primary Care-Based PTSD Intervention: Clinician-Supported PTSD Coach
2 other identifiers
interventional
234
1 country
2
Brief Summary
Posttraumatic Stress Disorder (PTSD) is an often severe and frequently disabling condition. It is associated with compromised health, early mortality, and substantial economic costs. PTSD is common in VA primary care patients; however, brief, effective treatments for PTSD are not available in the primary care setting. Instead, patients with PTSD are referred to mental health settings, yet many patients do not accept these referrals or do not adequately engage in such services. Thus, this project seeks to improve health care for Veterans by testing the effectiveness of a primary care-based treatment called clinician-supported PTSD Coach. In this treatment a primary care mental health clinician guides patients in using the PTSD Coach mobile app to learn about PTSD symptoms, treatment options, and strategies to cope with common PTSD-related concerns. If this treatment is found to be effective at reducing PTSD symptoms and increasing use of mental health care, it will provide a tremendous benefit to Veterans with PTSD seen in VA primary care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2016
CompletedFirst Posted
Study publicly available on registry
February 18, 2016
CompletedStudy Start
First participant enrolled
March 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedResults Posted
Study results publicly available
March 4, 2024
CompletedMarch 4, 2024
February 1, 2024
4.6 years
February 12, 2016
February 23, 2023
February 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinician Administered PTSD Scale for DSM-5 (CAPS-5)
The CAPS-5 is a 30-item clinical interview that assesses the 20 DSM-5 PTSD symptoms. Scores on the CAPS-5 can range from 0 to 80, with higher scores reflecting worse PTSD symptom severity. In this study, clinician-rated PTSD symptom severity were based on blind assessor ratings.
Baseline
Hospital Administrative Data Showing 2 Mental Health Visits Completed
Hospital administrative data will be examined to determine if the participant completed 2 visits to any specialty mental health clinic during the follow-up period.
16 and 24 weeks
Secondary Outcomes (5)
PTSD Checklist-5 (PCL-5)
Baseline, 8 week, 16 week, 24 week
Client Satisfaction Questionnaire (CSQ)
8 week
Patient Health Questionnaire (PHQ-9)
Baseline, 8 week, 16 week, 24 week
WHOQOL-BREF Psychological Health Subscale
Baseline, 8 week, 16 week, 24 week
WHOQOL-BREF Social Relationships Subscale
Baseline, 8 week, 16 week, 24 week
Study Arms (2)
Clinician-Supported PTSD Coach
EXPERIMENTALClinician-supported PTSD Coach is primary care-based treatment. In this treatment a primary care mental health clinician guides patients in using the PTSD Coach mobile app to learn about PTSD symptoms, treatment options, and strategies to cope with common PTSD-related concerns. It consisted of 4 brief sessions over 8 weeks.
Primary Care Mental Health Integrated Care as Usual
ACTIVE COMPARATORExisting primary care mental health integrated treatment will serve as the comparison condition
Interventions
Clinician-supported PTSD Coach is primary care-based treatment. In this treatment a primary care mental health clinician guides patients in using the PTSD Coach mobile app to learn about PTSD symptoms, treatment options, and strategies to cope with common PTSD-related concerns. It consists of 4 brief sessions over 8 weeks.
Existing primary care mental health integrated treatment will serve as the comparison condition
Eligibility Criteria
You may qualify if:
- Veterans enrolled in primary care within the VA Syracuse and Palo Alto healthcare systems reporting 33 on the PTSD Checklist-5 (PCL-5) and a traumatic event on the Criterion A screener
You may not qualify if:
- Patients will be excluded if they demonstrate symptoms that would not allow them to actively engage in the CS PTSD Coach, i.e.,
- gross cognitive impairment
- Current symptoms of mania or psychosis or who have more pressing concerns that need to be addressed first, i.e.,
- suicide attempt in the last two months or current intent to commit suicide
- Patients with recent suicide attempts or intent are eligible to be enrolled follow the receipt of suicide prevention services
- The investigators will also exclude patients that are already receiving psychotherapy or MH counseling for PTSD outside of PC
- Started or changed the dose of a psychotropic medication for PTSD in the last two months that was prescribed outside of VA PC
- Voice a preference to be directly referred to MH specialty care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, 94304-1290, United States
Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York, 13210, United States
Related Publications (1)
Possemato K, Johnson E, Barrie K, Ghaus S, Noronha D, Wade M, Greenbaum MA, Rosen C, Cloitre M, Owen J, Jain S, Beehler G, Prins A, Seal K, Kuhn E. A Randomized Clinical Trial of Clinician-Supported PTSD Coach in VA Primary Care Patients. J Gen Intern Med. 2023 Jul;38(Suppl 3):905-912. doi: 10.1007/s11606-023-08130-6. Epub 2023 Mar 17.
PMID: 36932268RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Eric Kuhn, PhD
- Organization
- VA Palo Alto Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Eric R Kuhn, PhD
VA Palo Alto Health Care System, Palo Alto, CA
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The CAPS-5 will be administered via phone by a central assessor, blind to condition, at baseline and post-treatment and will be the primary measure of change in PTSD symptom severity.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2016
First Posted
February 18, 2016
Study Start
March 1, 2017
Primary Completion
September 30, 2021
Study Completion
September 30, 2021
Last Updated
March 4, 2024
Results First Posted
March 4, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share